PALOSEIN - PWS LIQ IM SC DIN 02151006
Health Canada record
| Active ingredient(s) | ORGOTEIN 5 MG; SODIUM CHLORIDE 2 ML |
|---|---|
| Dosage form | Powder For Solution; Liquid |
| Route | Intramuscular; Subcutaneous |
| Schedule | ETHICAL |
| Class | Veterinary |
| ATC | M01AX14 ORGOTEIN |
| Original market date | 25-Sep-1997 |
| Current status date | 13-Sep-2001 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 7522 | 1995-02-01 | New Drug Submission (NDS) |
International API supply for ORGOTEIN
0 valid EDQM Certificates of Suitability from 0 holders. 0 active FDA Drug Master Files.
Request a quote for PALOSEIN - PWS LIQ IM SC